Pfizer, Scripps Research Institute Partner on DNA-Encoded Library Tech | GenomeWeb

NEW YORK (GenomeWeb) – The Scripps Research Institute (TSRI) announced today that it has partnered with Pfizer to develop a novel chemical synthesis technology for creating next-generation DNA-encoded libraries (DELs).

Under the terms of the deal, Pfizer will pay an undisclosed fee to gain access to a chemical synthesis technology developed at TSRI. The two will adapt this technology for use in creating DELs, and choose to expand their joint research to include other technologies enabling DEL-based drug discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.